Contact SCGE




SCGE Consortium Home   |  About SCGE Toolkit   |  Contact Us   |  Citing the Toolkit   |  License  
!
Scheduled Maintenance Notice

The site will be undergoing scheduled maintenance on Tuesday 7th July 2026 from 11:00AM to 1:00PM Central Time (CT). During this time, the site may be temporarily unavailable. We apologize for any inconvenience.

ExperimentGene editing in vitro by various peptide variants delivering Cas RNPs to primary Human airway epithelia cells.
Experiment ConditionS85, Cas9, CFTR
Assay Description: Calculated editing efficiency mean of 3 biological replicates by sanger sequencing.
Tissue Measured:
Measurement Type:Editing Efficiency
Record ID15000000545

EditorSpCas9 (Feldan Therapeutics)
Delivery SystemS85
Delivery System SubtypeAmphiphilic peptide
Guideg-11_C9
Vector

Model SpeciesHuman
Model NamePrimary Airway Epithelia

Application MethodIn Media
Application Site
Dosage[RNP]: 2.5 µM; [gRNA]: 2.0 μM; [Peptide]: 40uM
Injection Frequency
Injection Rate
Injection Volume
Days post injection72 hours
Editor Formatribonucleoprotein (RNP)
Antidote Id
Antidote Description

Measured Values
Samples Size: 1
 
Replicate Result (Editing Efficiency)
Measurement Units: % indel
Mean 9.00 
1 9.0 
  

Publication Title
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. NCBI